Trades on 1 secondary market

Satellite Bio

Satellite Bio is a biotechnology company developing off-the-shelf liver cell therapies to treat severe and life-threatening liver diseases. Its tissue therapeutics platform engineers functional hepatocytes designed to engraft and restore liver function, combining the biological power of liver cells

minimal 10.8 / 100 0 APIs View provider profile →

Company Biotechnology Life Sciences Cell Therapy Tissue Therapeutics Liver Disease

Satellite Bio is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.